Co-Diagnostics, Inc.
CODX · NASDAQ
Bulios Fair Price
$1.44
42.6% upside
Trenutna cena
$1.01
Po podatkih Bulios Fair Price je delnica CODX trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Co-Diagnostics, Inc. (CODX) is an American biotechnology company specializing in the development and manufacturing of diagnostic tests and reagent kits for the detection of various infectious diseases. The company focuses on innovative molecular diagnostic technologies that enable rapid and accurate determination of pathogens in patient samples. Its diagnostic tools are applied in the detection of viral, bacterial, and parasitic infections, serving both as diagnostic and monitoring solutions for diseases. With its advanced diagnostic technologies, Co-Diagnostics can contribute to improving healthcare and reducing the spread of infectious diseases. The company continually emphasizes research and development of new diagnostic tests to meet the needs of the medical community. Co-Diagnostics, Inc. (CODX) shares may be an attractive investment opportunity for investors interested in the healthcare sector and seeking an investment in a company dedicated to innovative diagnostic technologies.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Dwight Egan
Employees
115
Headquarters
Salt Lake City
Prihajajoči dogodki
Earnings
Upcoming earnings report